Safeguard® Pressure Assisted Device: Trusted Femoral Performance Now Available for Radial Procedures

Many of our customers use the Safeguard Pressure Assisted Device for hemostasis following femoral access procedures because they trust its compression, convenience and comfort. Merit Medical now has the Safeguard Radial™ compression device that offers the same trusted compression after radial procedures.


  • The Safeguard Radial’s inflatable bulb focuses compression only where you want it
  • It’s easy to adjust air in the bulb (inflation or deflation) using a standard Luer lock syringe
  • Trusted Compression, Comfort & Convenience
  • Now Available For Your Radial Procedures
  • The base plate and the way the band wraps around the bulb provides stable positioning, not occlusion
  • You already know how important patent hemostasis is for a radial compression device and the Safeguard Radial allows you to achieve patent hemostasis with patient comfort as well


  • While your patients come in many sizes, Safeguard Radial comes in one size that will fit them all
  • Having one compression device can reduce your inventory, maximize your precious storage space, and streamline ordering
  • You can use any syringe because Safeguard Radial has a standard Luer lock
  • The inflatable bulb lets you take distal and proximal pulses easily
  • The visibility of the clear bulb window allows you to check for oozing


  • Just like the Safeguard femoral, Safeguard Radial has a soft textile band with no plastic edges and a low profile design

So if you have been using the Safeguard for hemostasis following your femoral procedures, you can trust the Safeguard Radial to provide the same comfortable, convenient performance for radial compression.

Schedule an evaluation of the Safeguard Radial

Stephanie Poulsen
Senior Product Manager

Merit Medical Opens New Office in Tsim Sha Tsui, Kowloon, Hong Kong

Merit Medical Systems is pleased to announce the grand opening of a new office in Tsim Sha Tsui, Kowloon, Hong Kong. Merit Asia has been operating in Hong Kong for three years, and this larger office will help support our growing business with distributors in Hong Kong, Taiwan, and South East Asia.Joe Wright, President of Merit Technology Group was on hand to help with the ribbon cutting ceremony on June 12. Also pictured are Leon Lam, Vice President-Asia and Jo Choi, Regional Business Director for Hong Kong, Taiwan, and Southeast Asia.
Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures in several disciplines including cardiology, radiology, nephrology, vascular surgery, electrophysiology, and endoscopy. Our broad product portfolio includes therapeutic products for dialysis, embolization of uterine fibroids and tumors, and strictures of the airway.
Merit Medical’s new Hong Kong address is:
Room 901B, 9/F, Empire Centre
68 Mody Road, Tsim Sha Tsui
Kowloon, Hong Kong
Phone: +852 2628 3612 Fax: +852 2628 3130
歡迎 and 祝你好運 !

Multi-Center Trial Shows Significant Pain Relief For Spine Cancer Patients Following Targeted Radiofrequency Ablation Treatment

SAN JOSE, Calif. – July 21, 2014 – DFINE®, Inc., a market leader in the minimally invasive treatment of spinal diseases, today announced the publication of a multi-center study in the July/August issue of Pain Physician Journal, the official peer-reviewed publication of the American Society of Interventional Pain Physicians (ASIPP). The study followed patients at five leading academic centers and found a significant decrease (p<0.01) in pain scores after Targeted Radiofrequency Ablation™ (t-RFA) with the STAR Tumor Ablation System™.The participating centers included Washington University School of Medicine, Moffitt Cancer Center, Montefiore Medical Center and the Albert Einstein College of Medicine, University of Louisville Hospital and the University of California, San Diego. Physicians treated 128 lesions (metastatic tumors) in 92 patients. The average pain score before the procedure was 7.51 out of 10. Within one week post-procedure, the average pain score was reduced to just 1.73. Researchers also noted no patient complications or injuries.

“More than 40 percent of patients at the highest enrolling institution in this study had previous radiation treatment with little to no relief of symptoms,” said Jack W. Jennings, M.D., Ph.D, Assistant Professor and Director of Musculoskeletal and Spine Interventions, Mallinckrodt Institute of Radiology, Washington University School of Medicine in St. Louis. “Our study showed significant and almost immediate reduction in pain and more than half of the patients also decreased their use of pain medication. The procedure also allowed us to treat tumors close to the spinal cord that we have not been able to treat in the past.”

The American Cancer Society estimates that in 2014 there will be more than 1.7 million new cancer cases diagnosed and 585,720 cancer deaths in the United States.1 Metastatic lesions in bone are common and have been seen in up to 80 percent of patients with cancer at the time of death,2 with spinal metastasis seen in approximately 50 percent of these patients.3

“For late-stage cancer patients, extreme back pain due to spinal tumors degrades quality of life; and until now, limited minimally invasive procedural options for immediate pain relief have been available,” said Nam D. Tran, M.D., and Ph.D., neurooncology surgeon at Moffitt Cancer Center. “This multi-center study validates t-RFA as a treatment option that provides rapid, lasting pain relief without the need to interrupt the patient’s primary cancer therapy.”

About STAR™ Tumor Ablation System

t-RFA with the STAR System does not treat cancer. It is cleared by the FDA for providing palliative treatment (e.g. pain relief) by ablation of metastatic malignant tumors in a vertebral body. For a complete list of indications, risks and contraindications, visit—SpineSTAR

Treatment of Metastatic Posterior Vertebral Body Osseous Tumors by Using a Targeted Bipolar Radiofrequency Ablation Device: Technical Note

Travis J. Hillen, MD, Praveen R. Anchala, MD, Michael V. Friedman, and Jack W. Jennings, MD, PhD. Hillen, et al., Radiology. 2014 June 13:131664, E-pub prior to print Pubmed ID: 24927327   This article presented how targeted Radiofrequency Ablation (t-RFA) with the STAR Tumor Ablation System can serve as a Minimally Invasive Solution to Safely and Effectively Treat Previously Inaccessible Spinal Lesions



The STAR Tumor Ablation System:

  • Provides access to tumors that are difficult to reach with conventional ablation systems
  • Allows for safe & controlled ablation of spinal tumors
  • Does not hinder or delay other therapies
  • May provide an alternate therapy for tumors that do not respond to chemotherapy or radiation therapy

ReSolve® Biliary Locking Drainage Catheter Receives CE Mark!


I am pleased to announce that the ReSolve® Biliary Locking Drainage Catheter has received the CE mark and is available for sale in Europe.

These catheters are indicated for drainage of bile within the biliary system. Often biliary systems need to be decompressed due to bile duct stones, extrahepatic, or intrahepatic tumors, and primary sclerosing cholangitis, among other reasons. In addition bile may also need to be diverted from a bile duct leak.

Biliary system lesions do not always occur in the same location in every patient. Because of this, Merit offers catheters with two different drainage hole configurations to accommodate patient anatomy and multiple disease locations.

Correct catheter positioning is important in these procedures. The catheter features a radiopaque marker band near the proximal shaft drainage hole, and non-radiopaque depth markers the entire length of the catheter to help with fast and accurate positioning.

Additional features:

  • Atraumatic pigtail
  • Smooth transitions
  • Large drainage holes
  • Hydrophilic coating
  • Kink resistance

To learn more, check out the  ReSolve® Biliary Locking Drainage Catheter product webpage.

Richard Collard
Senior Product Manager
Merit Medical Systems, Inc.